SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015162
Filing Date
2018-08-10
Accepted
2018-08-10 08:31:15
Documents
48
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20180630_10q.htm 10-Q 537329
2 EXHIBIT 31.1 ex_119000.htm EX-31.1 15081
3 EXHIBIT 31.2 ex_119001.htm EX-31.2 15632
4 EXHIBIT 32.1 ex_119002.htm EX-32.1 10337
11 img01.jpg GRAPHIC 2807
  Complete submission text file 0001437749-18-015162.txt   3314470

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20180630.xml EX-101.INS 508723
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20180630.xsd EX-101.SCH 39602
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20180630_cal.xml EX-101.CAL 39455
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20180630_def.xml EX-101.DEF 289519
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20180630_lab.xml EX-101.LAB 282684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20180630_pre.xml EX-101.PRE 302593
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 181007084
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1